Voces por la Salud / Voices for Health, by Roche

A First Lady, a doctor, a healthcare and cancer care advocate… There is no shortage of words to describe Dr. Zainab Shinkafi A. Bagudu. Our latest guest, Dr. Zainab as we discuss her work, her drive and her determination to overcome the cultural, societal and systemic barriers preventing Nigerian women from accessing cancer care.

The covid pandemic highlighted the value of diagnostics in fighting pandemics and strengthening health systems. Countries with strong diagnostics systems were better equipped to respond to the pandemic. In this episode, we are going to talk about it with Doreen Shempela and Cynthia Banda, from The Church's Health Association of Zambia Laboratory

It's no secret, women's health has been traditionally underfunded. But the past few years have seen an upsurge in funding for women-led companies, thanks in part to efforts of companies like Springboard Enterprises, who've made it their mission to help drive innovation, research and investment in women's health. In this new episode of Voices for Women's Health, Teresa Graham – Head of Pharma Global Products Strategy (GPS) at Roche Pharmaceuticals – sits down with Springboard Enterprises CEO, Natalie Buford Young, for an empowering discussion around women's health and the need for greater equity in research and funding. Springboard Enterprises has been supporting women entrepreneurs in technology and life sciences for decades, working tirelessly to close the gaps in women's health by providing greater funding and research to women-led companies. “From a funding perspective, the venture capital industry is still predominantly male. There's only 13% percent of women in leadership roles and venture capital. That means that when you are a woman innovating in women's health and you're approaching a venture capitalist and trying to explain the latest pelvic floor solution, or something around menopause or maternal care. It's not that they don't care about it. It's that everyone invests in what they know, and they just don't know these areas.”Natalie Buford Young, CEO of Springboard Enterprises 

En este episodio contamos con la Dra. Judith Zilberman para conversar acerca de las enfermedades cardiovasculares (ECV) y las diferencias entre cómo afectan a los hombres y las mujeres. Las ECV son la primera causa de muerte en el mundo, inclusive entre las mujeres; sin embargo, la creencia de que las condiciones ginecológicas son la primera amenaza a la salud femenina suele restar atención al problema. Escucha el episodio para saber más acerca de los factores de riesgo, los síntomas y cómo prevenirlas.

Virginia Abello, presidente de la Junta Directiva de la Asociación Colombiana de Hematología y Oncología (ACHO), nos habla sobre cómo podemos hacer frente a las barreras del acceso a una atención oncológica de calidad y reforzar la capacidad de recuperación de los sistemas sanitarios ante futuras emergencias, partiendo del análisis de los aprendizajes y repercusiones que ha traído el Covid-19.  

Oncologist Dr Matteo Lambertini believes it's important to empower female patients, as well as improve the networks between oncologists and fertility experts. Listen now as he talks to Maura Dickler  about what it takes to remove the barriers - and why it all begins with clinical trials.“Now, as physicians, as medical oncologists, we have more responsibilities because it's not only the cure of the disease, but it's also to avoid as much as possible the side effects… We need to pay more attention when we design clinical trials to try to focus on the survivorship issues.” Dr Matteo Lambertini

En el marco del Día Mundial de Hemofilia, conversamos sobre el potencial del trabajo en red en la comunidad de Hemofilia para alcanzar el acceso a una atención integral, con Isabel Sorondo, Presidente de la Asociación de Hemofilia de Uruguay, y Alex Muñoz, Médico experto en políticas públicas y gestión de riesgo en Hemofilia.

Receiving the news that you have cancer is beyond compare. But in addition to the shock of the news comes the challenge of navigating the journey ahead. Imagine not knowing whom to go to for which information or only realising, when its too late that there are steps you should have taken before you started chemotherapy. For Indyra Oropeza Aguilar, the journey started with some amazing doctors and help. But she soon realised that not everyone has the same access to information and healthcare. She has since started a blog, become a patient advocate, founded non-profit organisation and is currently driving support to implement the National Cancer Law in Peru which will seek to provide all oncology patients in Peru with access to dignified and a high quality of health care.Indyra believes that information is power. Listen to our latest podcast episode now for this inspirational story and empowering thoughts! 

In this episode we talk to Mah-Sere Keita, Director of Programs, African Society for Laboratory Medicine. With over 15 years experience in managing global health programs, Man-Sere particularly focuses on the fields of public health workforce development and improving the diagnosis of infectious diseases in low-resource settings. Man-Sere shares her thoughts on why focusing on women's health is integral to future proofing African healthcare.

Uma gestão sustentável da saúde, orientada pelos benefícios gerados aos pacientes e capaz de reduzir o desperdício de recursos no setor. Este é o propósito de value-based healthcare (VBHC) - ou, em português, medicina baseada em valor. Quer saber mais sobre o tema? Neste episódio do Vozes pela Saúde, o Dr Cesar Abicalaffe, presidente do Instituto Brasileiro de Valor em Saúde (IBRAVS), explica os desafios e benefícios para a implementação desta abordagem no Brasil.

Dra. Lucía Rodich, Ginecóloga Oncóloga. Cédula Colegio Médico 63393. Registro Nacional de Especialistas RNE23318 (Ginecología Oncológica). Lo comentado en este episodio es sustentado y responsabilidad de los médicos. Consulta a tu médico para mayor información.

In this episode, you will meet Dr. Daniel Kraft, a Stanford and Harvard-trained physician and innovator, who serves as faculty chair for medicine at Singularity University. Daniel has over 25 years of experience in clinical practice and healthcare innovation. We spoke to him about how crises force new ways of thinking, how the pandemic has accelerated collaboration and scientific progress, potentially ushering in data-driven, more personalised healthcare in the future.

Embora algumas doenças individualmente possam ser consideradas raras, coletivamente elas são tudo, menos isso. Segundo o Ministério da Saúde, 13 milhões de brasileiros convivem com essa condição. Para saber mais sobre este universo e os cuidados fundamentais à primeira infância, escute o novo episódio do Vozes pela Saúde com Stephanie Amaral, Oficial de Saúde do UNICEF. No podcast, você também conhecerá um projeto inédito, conduzido em parceria pela Roche e UNICEF para colaborar com melhorias na atenção primária de saúde para crianças com doenças raras, deficiências e déficit de aprendizagem.

In this episode, you will meet Dr. Robert Winn, Director, VCU Massey Cancer Center, who is at the forefront of addressing health disparities, promoting health equity, and advocating for diversity and inclusion in healthcare. We spoke to him about how the zip code is a better predictor of a person's life expectancy than genetics, how did the pandemic disproportionately impacted women, and lastly, how the place and space where a woman lives.

Muita gente não sabe, mas é possível contribuir para as discussões sobre quais medicamentos, procedimentos e tecnologias devem ou não serem incorporados aos sistemas de saúde. Neste episódio do Vozes pela Saúde, Aline Silveira Silva, PHD em Ciências e Tecnologias em Saúde e pesquisadora da Universidade de Brasília, explica a importância das ferramentas de participação pública para uma gestão mais assertiva da saúde. Para conhecer mais sobre o trabalho de Aline, siga @_opaciente no Instagram.

Con el avance en la comprensión del cáncer de mama, así como la evolución en el diagnóstico y tratamiento, nos encontramos en un momento trascendental para vencer a esta enfermedad. El abordaje integral y el trabajo articulado entre los distintos actores de los sistemas sanitarios juegan un papel fundamental. Para profundizar sobre el estado y desafíos en Latinoamérica, conversamos con la Dra. Isabel Alvarado, Jefa del Servicio de Patología en el Hospital de Oncología del Centro Médico Nacional Siglo XXI, del Instituto Mexicano de Seguridad Social y con el Dr. Rubén Torres, Rector de la Universidad ISalud de Argentina, y ex consultor Regional en Políticas y Sistemas de Salud de Organización Panamericana de la Salud.

Hello and welcome to Voices for Health, a channel from Roche where we will reflect on the challenges and opportunities facing women around the world. My name is Teresa Graham, and I'm the Head of Global Product Strategy at Roche. Our healthcare systems are failing women and that's a fact that is becoming even clearer after COVID-19. We fundamentally have to set a new and different agenda to better provide outcomes for our mothers, daughters and sisters that are better and surpass what we've been able to achieve today. Women are so central to our lives and society. Thinking about ways to improve health care for women around the world has been on my mind for a long time. And inequalities in healthcare exist everywhere, no matter how mature systems are and COVID-19 has revealed the systemic gender biases in healthcare systems around the world. We've analyzed patient journeys through women, and one thing stands out --  there is a need for so much more, than just medicine. To overcome the many hurdles in their path, women need tools, integrated solutions. To make a difference, we need to look at the whole process of innovation in healthcare from the clinical trials being tested at the right populations to efficiencies and delivery and access to our innovations. We have to look at integrated holistic solutions for women and for healthcare systems to set a new agenda, but what does good look like,where should we begin and how do we achieve meaningful lasting change?When we want to tackle issues of this magnitude, we want to start by listening to remarkable leaders who can talk about their own experiences, and today I am joined by just such a person Dr Stacy Rosen.Dr Rosen is the Senior Vice President of Women's Health at the Katz Institute for Women's Health, Northwell Health which focuses on the elimination of health care disparities through comprehensive clinical programs, gender-based research, community partnerships and education. A practicing cardiologist Dr Rosen is co-author of the 2018 book Heart Smart for ‘Women: Six S.T.E.P.S. in Six Weeks to Heart-Healthy Living' which equips women of all ages with the comprehensive program for heart-healthy living. Dr Rosen is a passionate advocate for comprehensive and integrated approach to women's health and i'm excited to have the opportunity to talk with her today WHAT IS VOCES POR LA SALUD / VOICES FOR HEALTH, BY ROCHE ?The Voices for Health podcast brings together voices of experts, policy makers and researchers to explore and determine ways to solve some of society's most pressing health-related questions. Together we discuss how to achieve and enable safe access to quality care for each and every citizen in a sustainable and lasting way.

Hello and welcome to Voices for Health, a channel from Roche where we will reflect on the challenges and opportunities facing health systems around the world. My name is Teresa Graham, and I'm the Head of Global Product Strategy at Roche. And today we have the pleasure of talking with Dr Lydia Dsane-Selby who has done so much to support women with cancer in Ghana.Our healthcare systems are failing women and that's a fact that is becoming even clearer after COVID-19. We fundamentally have to set a new and different agenda to better provide outcomes for our mothers, daughters and sisters that are better and surpass what we've been able to achieve today. Women are so central to our lives and society, but the question is, what does good look like, where do we begin and how do we achieve meaningful lasting change? As always when you think about tackling issues of this magnitude, you always want to start by listening. And I have the opportunity today to listen to a remarkable woman. Let me introduce Dr Lydia Dsane-Selby, who has done so much to ensure that women with cancer have insurance coverage in Ghana. Lydia is the Chief Executive of Ghana's National Health Insurance Authority; she's a trained doctor and ear, nose and throat specialist and has practiced in both the United Kingdom and Ghana. She has achieved something truly remarkable in Africa in a public health setting with limited resources with patients who may only have to pay out of pocket for their medicines. She has ensured that both breast and cervical cancer are within the benefit package for NHI.  WHAT IS VOCES POR LA SALUD / VOICES FOR HEALTH, BY ROCHE ?The Voices for Health podcast brings together voices of experts, policy makers and researchers to explore and determine ways to solve some of society's most pressing health-related questions. Together we discuss how to achieve and enable safe access to quality care for each and every citizen in a sustainable and lasting way.

En el marco del Día Mundial de la Hemofilia, conversamos sobre el estado y acceso de la atención integral de esta condición en América Latina con César Garrido, presidente de la Federación Mundial de Hemofilia, y Andrea Lisman, madre portadora y líder de un grupo de apoyo en Colombia. La hemofilia es un trastorno de la sangre que puede tratarse de manera adecuada, por medio de la atención integral, un enfoque de cuidado preventivo que permite que las personas que viven con ella, desarrollen su potencial.

¿Cómo puede América Latina acelerar su búsqueda de inmunidad para el COVID-19? Dialogamos con los doctores Pablo Bonvehí y Carlos Arturo Alvarez Moreno sobre los desafíos de trabajar colaborativamente entre gobierno, academia, sector privado y sociedad civil; y la importancia de tomar decisiones basadas en la evidencia.

O câncer não entende fronteiras de tempo, geográficas e nem de pandemias. Durante 2020, milhões de pacientes ao redor do mundo interromperam os seus tratamentos ou não receberam a atenção médica necessária. Neste Dia Mudial do Câncer conversamos com Gilberto Lopes, médico oncologista e membro da União Internacional Contra o Câncer, sobre a necessidade de priorizar a prevenção, detecção e tratamento do câncer durante a pandemia de Covid-19.

As the world battles against the worst pandemic in a hundred years, cancer didn't just go away. In 2020, over 19 million people worldwide were affected by cancer, and almost ten million people died.Cancer doesn't wait for anyone. Not even a pandemic.  Where early detection had to be delayed... where medical care was affected or simply overwhelmed in it's struggle to cope with rising Covid-19 numbers... or continuing treatment became more remote and more difficult, cancer carried on regardless and unperturbed.  According to the World Health Organization, over 50 percent of all countries partially or totally interrupted cancer care services to respond to the Covid-19 emergency.Welcome to a new episode of Voices for Health. In acknowledgement of World Cancer Day, we spoke with Gilberto Lopes about the initiatives of the Union for International Cancer Control, UICC, to provide continuity of care for cancer during this pandemic. We discussed the importance of promoting cancer prevention, detection, and treatment as a public health priority, facing the growth of Non-Communicable-Diseases and their impact on health systems.

El cáncer no entiende de fronteras temporales, geográficas, ni de pandemias. Durante el 2020 millones de pacientes con cáncer alrededor del mundo quedaron "en pausa" sin recibir atención médica o interrumpiendo sus tratamientos.  En este Día Mundial del Cáncer conversamos con Gilberto Lopes, médico oncólogo y miembro de la Unión Internacional contra el Cáncer, sobre la necesidad de priorizar la prevención, detección y tratamiento del cáncer durante la pandemia del Covid-19.

The actions and behaviors of citizens can have a significant impact on individual and collective well-being. We talked with Alberto Alemanno, expert in public policy and author of  the book "Lobbying for change: Find Your Voice to Create a Better Society", about the role of citizens in transforming health systems.Alberto is a lawyer, professor, author and expert in public policy. He graduated from Harvard Law School and the College of Europe and holds a PhD in International Law & Economics from Bocconi University. His research centers on how law can improve people's lives, through the adoption of power-shifting reforms.

Hoje, vamos falar com Frederico Guanais, diretor adjunto da Divisão de Saúde da OCDE, a Organização para a Cooperação e o Desenvolvimento Econômico.Frederico Guanais é formado em engenheira civil pela Universidade Federal da Bahia, tem um máster da mesma instituição e doutorado em Administração Pública, Política de Saúde e Gerenciamento pela Universidade de Nova Iorque.Já atuou nos ministérios de Finanças, Segurança e Desenvolvimento Social no Brasil, assim como no Banco Interamericano de Desenvolvimento. Falamos com ele sobre a importância de desenvolver um sistema de saúde no qual o paciente tenha o lugar central.

El COVID-19 ha tenido un gran impacto en los pacientes que padecen enfermedades crónicas en todo el mundo.  Desde que comenzó la pandemia, muchas personas con necesidad de tratamiento para múltiples patologías, -incluido el cáncer- no han recibido a tiempo ni los controles ni los cuidados que precisan. Esto es porque los servicios de atención médica se han interrumpido parcial o totalmente para dar respuesta a la emergencia del coronavirus. Entonces, ¿Cuál es la magnitud de esta disrupción de los servicios de salud en los pacientes oncológicos en las ciudades de América Latina? ¿Y cómo se va a manejar el incremento en la demanda de atención de estos pacientes en el mediano y largo plazo?Los sistemas de salud latinoamericanos y sus prestadores de servicios sanitarios enfrentan una serie de desafíos y oportunidades sin precedentes. La atención oportuna de los pacientes dependerá de la capacidad de implementar intervenciones efectivas, que articulen a los actores públicos y privados de forma acelerada, y con la flexibilidad necesaria para adaptarse a los cambios continuos que ha traído la crisis sanitaria.En el episodio de hoy hablaremos con Maria Fernanda Navarro sobre  cómo mejorar el acceso al diagnóstico y tratamiento del cáncer de una forma equitativa, de calidad, en las ciudades de los países de bajos y medianos ingresos. María Fernanda es directora regional de City Cancer Challenge Foundation para América Latina. Es médica de la Pontificia Universidad Javeriana de Colombia y tiene una maestría en Salud Pública de la Escuela de Salud Pública de la Universidad de Harvard. En sus 18 años de experiencia en el sector salud, ha sido directora administrativa del Instituto de Cáncer Dana-Farber, directora regional de Americas Health Foundation y, desde 2020, directora regional de City Cancer Challenge Foundation.

The COVID-19 pandemic has tremendous implications for the health, economy and social cohesion of countries. Governments across the world will have to face these challenges for years to come. From weakened economies and fractured health systems to high unemployment levels, crumbling social programs and increased social unrest. This pandemic has shown us clearly that health is a core determinant of social and economic development; thus, we need to ensure health systems are equipped to address the current and future challenges, as well as the needs of the population. In this session, experts will discuss the challenges COVID-19 presents for the construction of sustainable health systems and what the role of governments should be as we transition to a “new normal.”Dr. Rifat Atun, Director of Global Health Systems Cluster at Harvard University, talks in this interview about the challenges that Health Systems in emerging countries are facing now, and how this crisis can lend opportunities.  

Today, we will talk with Frederico Guanais, Deputy Head of the Health Division at the OECD, the Organization for Economic Co-operation and Development, about people-centered Health Systems. Frederico graduated with a degree in civil engineering from the Universidade Federal da Bahia and earned a master's degree from the same institution. He also earned a Ph.D. in Public Administration, Health Policy and Management from New York University. Prior to joining the OECD, he has worked with the ministries of Finance, Social Security, and Social Development in Brazil, as well as for the Inter-American Development Bank as Principal Health Specialist. 

In this episode of Voices for Health, a podcast by Roche, we focus on Personalized Healthcare or Precision Medicine. Personal health care is not a single intervention, it is a paradigm shift. Alan Lovell, from The Economist Intelligence Unit, says: "it's not possible to say that yet every intervention under the personalized medicine umbrella will prove worthy to adopt.  You know, that's true of any area of medical innovation.  But, having said that, the evidence does suggest that many personalized treatments, when spread across the Health System, are not only cost effective, but can actually lead to substantial savings and improve patient outcome. A study conducted in France found that investing just one point seven million euros in genetic testing for lung cancer patients could cut treatment costs by nearly seventy million euros". 

Alberto Alemanno es graduado de la Escuela de Derecho de Harvard y el Colegio de Europa y tiene un doctorado en Derecho y Economía de la Universidad Bocconi. Su investigación se centra en cómo la ley puede mejorar la vida de las personas, mediante reformas que propicien los cambios de poder. Es profesor de la Facultad de Políticas Públicas de la Universidad de Tokio, el Colegio de Europa y académico en el Instituto O'Neill para Legislación de Salud Global. En 2015 fue nominado Joven Líder Global por el Foro Económico Mundial.En este episodio, Alberto hablará sobre las acciones y comportamientos de los ciudadanos pueden tener un impacto significativo en el bienestar individual y colectivo. Estudios recientes revelaron el beneficio sustancial de usar máscaras faciales y practicar el distanciamiento social en la lucha contra COVID-19. Del mismo modo, las investigaciones han demostrado que mantener un estilo de vida saludable y evitar el consumo de cigarrillos, alcnohol y alimentos procesados puede reducir los factores de riesgo asociados con las enfermedades no transmisibles, y la carga que implican para los sistemas de salud. La participación activa de los ciudadanos es clave para impulsar una transformación que conduzca a instituciones más centradas en las personas. Pero, ¿Cómo se puede capacitar y empoderar a los ciudadanos para que sean los protagonistas de los procesos de transformación de los sistemas de salud?  

En el episodio de hoy hablaremos con Felicia Knaul, Directora del Instituto para Estudio Avanzado de las Américas y profesora de la Miller School de Medicina en la Universidad de Miami.Doctora en Economía por la universidad de Harvard, Felicia investiga el acceso a la salud en países de ingresos bajos y medianos, en especial para la mujer y el niño. El cáncer de mama, su prevención y tratamiento desde el punto de vista de los sistemas de salud es uno de los temas principales de su agenda.Felicia es también fundadora y presidenta de Tómatelo a Pecho, una ONG dedicada a la salud femenina, y lidera investigaciones sobre sistemas del sector con la Fundación Mexicana para la Salud.Nos interesa hablar con ella de cómo el foco en el COVID-19 ha afectado el cuidado y prevención del cáncer en los países de América Latina teniendo en cuenta que, según una encuesta de la Organización Mundial de la Salud, un 42 por ciento de los países ha interrumpido los tratamientos de esta enfermedad para atender las urgencias de la pandemia.

Hoy vamos a hablar con Frederico Guanais, director adjunto de la División de Salud de la Organización para la Cooperación y el Desarrollo Económico (OCDE) desde el año pasado.Frederico se graduó como ingeniero civil en la Universidad Federal de Bahia, tiene un master de esa misma institución y un doctorado en Administración Pública, Políticas de Salud y Gerenciamiento, de la New York University.Previo a sumarse a la OCDE, se ha desempeñado en los ministerios de Finanzas, Seguridad Social y Desarrollo Social del Brasil, así como en el Banco Interamericano de Desarrollo, como su principal especialista en salud.Hablamos con él de la importancia de diseñar sistemas de salud centrados en las personas.

En este episodio de Voces por la salud, un podcast de Roche vamos a ver cómo la economía del comportamiento, una rama de la economía que busca explicar el componente no racional de las conductas económicas, puede ayudarnos a comprender mejor la salud pública. El COVID-19 ha puesto de manifiesto la necesidad de una mayor articulación entre las políticas de salud pública y desarrollo social y de prestar una atención renovada al papel que el sector privado puede cumplir en algunas esferas a partir de APP. La pandemia también reveló que la infraestructura sanitaria es inadecuada y que las instalaciones carecen de la capacidad de gestión y la fuerza de trabajo necesarias para hacer frente a las crecientes demandas de atención de su población. El contexto actual presenta una oportunidad única para replantear y establecer colaboraciones transformadoras entre los sectores público y privado a fin de crear soluciones sostenibles que permitan hacer frente a algunos de los desafíos que se plantean a los sistemas de salud. Emmanuel Ferrario analiza en esta entrevista estos problemas desde la óptica de su propia disciplina. 

Si bien la pandemia ha puesto de manifiesto profundas limitaciones en la capacidad de los países para recopilar, analizar y compartir datos de calidad, también nos ha mostrado el potencial de las soluciones digitales para superar las barreras de acceso a la atención médica. A medida que los gobiernos se preparan para hacer frente a las consecuencias críticas de esta pandemia, se necesitan intervenciones más específicas que conduzcan a un uso más eficiente y eficaz de los recursos. También hay una mayor necesidad de adoptar decisiones informadas, basadas en datos, a fin de crear sistemas de salud resistentes y sostenibles.Marcelo D'Agostino, experto en Sistemas de Información y Salud Digital, y asesor de la Organización Panamericana de la Salud, nos hablará de esto y mucho más en este episodio.En su trabajo diario Marcelo desarrolla, administra y comparte información de los países miembros de la OPS. Esa información técnica y científica es usada para promover acciones políticas, sociales e individuales necesarias para el funcionamiento de los sistemas de salud. 

A gente imagina um 2030 com o ser humano pisando Marte, com veículos autônomos, alcançando níveis jamais pensados de evolução em inteligência artificial... mas, a gente terá saúde para todos?Vivemos um presente incerto, complexo e ao mesmo tempo fascinante.  Com inovações que uns anos atrás no teríamos imaginado, e que têm o potencial de transformar a vida das pessoas, e a dos seus seres queridos.Porém, existem mesmo assim grandes desigualdades no aceso ao bem-estar, impedindo que o valor da inovação alcance a todos do mesmo jeito.Sejam bem-vindos a Vozes pela Saúde, um canal de Roche onde convidamos vocês a refletir sobre os desafios e oportunidades que hoje enfrentam os sistemas de saúde para segurar o aceso aos cuidados de qualidade para todos os pacientes do hoje e do amanhã. 

Imaginamos un 2030 con el ser humano pisando Marte, con vehículos autónomos, alcanzando niveles impensados de evolución en inteligencia artificial...pero tendremos ¿salud para todos?Vivimos un presente incierto, complejo y a su vez fascinante. Con innovaciones que años atrás no hubiéramos imaginado, y que tienen el potencial de transformar la vida de las personas y sus seres queridos. Sin embargo, también existen grandes desigualdades en el acceso al bienestar, que impiden que el valor de la innovación alcance a todos por igual. En este canal,  conversaremos con investigadores, profesionales de la salud, policymakers, innovadores y representantes de pacientes. Sus voces nos ayudarán a enfrentar el desafío que más nos concierne:  ¿Cómo podemos preparar a los sistemas de salud para adoptar la medicina del futuro? 

When you imagine the year 2030 what do you picture - perhaps humans settingfoot on Mars, self-driving cars, perhaps even incredible levels of A.I. supportingall aspects of our lives.... But, ask yourself, do you believe will we truly haveuniversal healthcare, for everyone?We are living in uncertain times; it is both complex and fascinating, and we areseeing and in some cases benefitting from innovations that we could not havedreamed possible just a few years ago - developments with the potential totransform people's lives.Yet amongst all this promise, there remains enormous inequalities in people'saccess to health care, which in turn impacts their well-being and the durationand quality of their lives.Hello and welcome to Voices for Health, a channel from Roche where we willreflect on the challenges and opportunities facing health systems around theworld as they seek to offer safe access to quality care for each and everypatient, today and tomorrow.In this podcast, we'll be talking to researchers, health professionals,policymakers, innovators and patient advocates. Their voices will help us toexplore and hopefully determine ways to some of our society's most pressingquestions:How can we prepare health systems for the innovations and advances of thefuture?How can we improve citizens' quality of life and their access to healthcare?And how can we do this without compromising the sustainability of healthsystems?